BTIG analyst Lance Jessurun reaffirmed a Neutral rating on PayPal (NASDAQ:PYPL) stock, expressing caution ahead of the ...

In a report released today, Julian Harrison from BTIG maintained a Buy rating on Cullinan Management (CGEM – Research Report), with a price ...

Neuronetics Inc (STIM) stock saw a modest uptick, ending the day at $3.01 which represents a slight increase of $0.47 or 18.50% from the prior close of $2.54. The stock opened at $2.67 and touched a ...

Cerus Corp (CERS) stock saw a decline, ending the day at $2.12 which represents a decrease of $-0.03 or -1.40% from the prior close of $2.15. The stock opened at $2.13 and touched a low of $2.05 ...

BTIG analyst Vincent Caintic maintained a Buy rating on Atlanticus Holdings (ATLC – Research Report) yesterday and set a price target of ...

Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, toda ...

Market technician Jonathan Krinsky analyzes the shift in market leadership from technology to healthcare amid recent ...

But before that let's have a chartist view from BTIG's technical guru Jonathan Krinsky. He notes that the S&P 500's rally off this week's lows is quite impressive and sets up the stock barometer ...

Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment rating to "Neutral" from "Buy" on Tuesday. The research firm said its ...

On Friday, BTIG initiated coverage on ImmunityBio Inc (NASDAQ:IBRX) with a Buy rating and a price target of $6.00. The firm sees potential in the company's lead product, ANKTIVA, an IL-15 receptor ...